Objectives: The aim of this study was to determine the relationship between lipoprotein
(a)[Lp (a)] and cardiovascular disease (CVD) in a large cohort of patients with heterozygous …

Background and aims Patients with familial hypercholesterolemia (FH) are often
characterized by premature coronary artery disease (CAD) with heterogeneity at onset. The …

Background: The role of lipoprotein (a)[Lp (a)] as a predictor of cardiovascular disease
(CVD) in patients with heterozygous familial hypercholesterolemia (HFH) is unclear. We …

Background Lipoprotein (a) is an atherogenic low-density lipoprotein–like particle and
circulating levels are largely determined by genetics. Patients with familial …

Aims The aims of the study were, first, to critically evaluate lipoprotein (a)[Lp (a)] as a
cardiovascular risk factor and, second, to advise on screening for elevated plasma Lp (a), on …

Lipoprotein (a)[Lp (a)] is a quantitative genetic trait that in the general population is largely
controlled by 1 major locus—the locus for the apolipoprotein (a)[apo (a)] gene. Sibpair …

Background: Genomic analyses have suggested that the LPA gene and its associated
plasma biomarker, lipoprotein (a)(Lp [a]), represent a causal risk factor for coronary heart …

There is compelling evidence that the elevated plasma lipoprotein (a)[Lp (a)] levels increase
the risk of atherosclerotic cardiovascular disease (ASCVD) in the general population. Like …

Abstract Lipoprotein (a)[Lp (a)] is composed of 1 low-density lipoprotein (LDL) particle, to
which 1 molecule of apolipoprotein (a) is covalently linked. Elevated levels of Lp (a) have …

Background: Raised plasma lipoprotein (a)(Lp (a)) is associated with increased risk of
cardiovascular disease. It is unknown whether increased Lp (a) is an additional risk factor for …